High Purity Raw Material Naltrexone HCl Powder Pharmaceutical Naltrexone

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: QS-Naltrexone
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Naltrexone
• Name: Naltrexone Powder
• Appearance: White Powder
• Colour: White
• Grade: Pharmaceutical Grade
• Assay: >99%
• Application: API
• Specific: COA
• Test Method: HPLC
• CAS: 16676-29-2
• Mf: C20h24clno4
• MW: 377.87
• Melting Point: 274-2760c
• Einecs: 240-723-0
• Storage Temperature: 2-8c
• Transport Package: Negotiable
• Specification: >99%
• Trademark: QS-Naltrexone
• Origin: Xian
• Production Capacity: 500kg/Month

Product Description

High Purity Raw Material Naltrexone Hcl Powder Pharmaceutical Naltrexone

Product Description

Product Details

Product Name	Naltrexone
Appearance	White Powder
Assay	99%
MW	349.317
MF	C16H14F3N5O

Naltrexone can reduce the craving for alcohol and lower the risk of relapse for abstainers. In the macaque experiment, different doses of Naltrexone were able to weaken the ethanol enhanced response at different ethanol concentrations, and effectively and dose dependently inhibit the ethanol demand generated by non accidental transmission of liquid ladles filled with 8% ethanol. At the same time, it significantly inhibits ethanol self administration and prevents ethanol induced increase in dopamine levels.

Application&Function

Blocking the effects of opioid substances: Naltrexone is an opioid receptor antagonist that competes with opioid receptors for binding, blocking the effects of exogenous opioid substances on the brain, reducing or eliminating cravings and desires caused by dependence, and helping patients gradually quit opioid addiction (such as , , etc.). For example, for individuals who have developed a dependence on opioid drugs, naltrexone can bind to opioid receptors and block the drug's effects on the brain.
Relieve withdrawal symptoms: Patients with opioid addiction may experience withdrawal symptoms such as anxiety, distress, nausea, vomiting, and general discomfort after discontinuing the medication. Naltrexone blocks opioid receptors, reduces the effects of opioid drugs on the brain, and thus alleviates these withdrawal symptoms, improving the success rate of withdrawal for patients.
Reducing the risk of relapse: As a long-term maintenance medication for rehabilitation treatment, long-term use of Naltrexone can prevent patients from resuming opioid use and reduce the risk of relapse. Its long-acting formulation can provide sustained drug effects, reduce the burden of frequent medication on patients, provide a stable rehabilitation environment, help patients establish withdrawal habits, and restore social function. For individuals who have already withdrawn from opioid drugs but are at risk of relapse, naltrexone can also effectively reduce the risk of relapse and maintain long-term rehabilitation outcomes.
Increasing treatment compliance: Naltrexone can form a protective measure, even if patients are exposed to opioids again during the withdrawal process for some reason, its presence can prevent the drug from affecting the brain, reduce the abuse effect of the drug, help patients persist in the recovery process, and gradually establish self-control over opioids.

Specification